Search

Your search keyword '"Yoichi Tatsumi"' showing total 98 results

Search Constraints

Start Over You searched for: Author "Yoichi Tatsumi" Remove constraint Author: "Yoichi Tatsumi"
98 results on '"Yoichi Tatsumi"'

Search Results

1. Total metabolic tumor volume as a survival predictor for patients with diffuse large B-cell lymphoma in the GOYA study

2. Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy

Catalog

Books, media, physical & digital resources

3. Genital Infection as a First Sign of Acute Myeloid Leukemia

4. Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group

5. Cellulitis with Leukocytopenia as an Initial Sign of Acute Promyelocytic Leukemia

6. Novel prognostic predictor of haemoglobin–platelet index in diffuse large B‐cell lymphoma, not otherwise specified: Anaemia and thrombocytopenia are associated with <scp>IL</scp> ‐6 production in lymphoma cells

8. Long-term effectiveness and safety of high dose chemotherapy followed by autologous stem cell transplantation in daily practice in patients with diffuse large B-cell lymphoma

9. Decreased expression of T-cell-associated immune markers predicts poor prognosis in patients with follicular lymphoma

10. CD34

11. Decreased Expression of T-Cell-Associated Immune Markers Predicts Poor Prognosis in Patients with Advanced Follicular Lymphoma Received Rituximab Plus Bendamustine

12. End-of-treatment PET/CT predicts PFS and OS in DLBCL after first-line treatment: results from GOYA

13. Tumour-immune microenvironment in duodenal-type follicular lymphoma

14. Synchronous Occurrence of Mycosis Fungoides, Diffuse Large B Cell Lymphoma and Acute Myeloid Leukemia

15. Romidepsin in Japanese patients with relapsed or refractory peripheral T-cell lymphoma: a phase I/II and pharmacokinetics study

16. The gamma chain of the high-affinity receptor for IgE is a major functional subunit of the T-cell antigen receptor complex in gamma delta T lymphocytes

17. Influences of red cell deformability on trapped plasma volume

18. Classic Hodgkin Lymphoproliferative Diseases Clonally Unrelated to B-Chronic Lymphocytic Leukemia Successfully Treated with Bendamustine Plus Rituximab

19. [Successful treatment of secondary graft failure with donor lymphocyte infusion in a post-allogeneic stem cell transplant acute myeloid leukemia patient]

20. Biology and Pathology of B-Cell Lymphoma

21. Fluorescent silica nanoparticles modified chemically with terbium complexes as potential bioimaging probes: their fluorescence and colloidal properties in water

22. Azacitidine therapy for low-risk myelodysplastic syndrome developing after solid organ transplantation

23. Obinutuzumab or Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Previously Untreated Diffuse Large B-Cell Lymphoma

24. Post-herpes zoster sarcoidosis as a recurrence

25. Clinical importance of human herpes virus-8 and human immunodeficiency virus infection in primary effusion lymphoma

26. Successful Allogeneic Hematopoietic Stem Cell Transplantation in a Young Patient with Richter Syndrome Presenting with Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma with Different Cell Origins

27. A case of intraocular lymphoma with central nervous system involvement and high interleukin-10 levels in both vitreous humor and cerebrospinal fluids: successful treatment with a combination of intravitreal, intrathecal, and systemic therapy

28. END OF TREATMENT PET-CT PREDICTS PROGRESSION-FREE SURVIVAL IN DLBCL AFTER FIRST-LINE TREATMENT: RESULTS FROM THE PHASE III GOYA STUDY

29. Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group

30. Prognostic implication of types of tumor-associated macrophages in Hodgkin lymphoma

31. Fluorodeoxyglucose uptake in the bone marrow after granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma

32. A Case of Chronic Myelomonocytic Leukemia Who Developed Pericardial Effusion during Stably Controlled Leukocytosis

33. Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome

34. Change of CD20 Expression in Diffuse Large B-Cell Lymphoma Treated with Rituximab, an Anti-CD20 Monoclonal Antibody: A Study of the Osaka Lymphoma Study Group

35. A case of cutaneous gamma/delta T-cell lymphoma

36. All-trans retinoic acid attacks reverse transcriptase resulting in inhibition of HIV-l replication

37. HIV-negative Primary Bone Marrow Hodgkin Lymphoma Manifesting with a High Fever Associated with Hemophagocytosis as the Initial Symptom: A Case Report and Review of the Previous Literature

38. Heterogeneity of intratumoral (111)In-ibritumomab tiuxetan and (18)F-FDG distribution in association with therapeutic response in radioimmunotherapy for B-cell non-Hodgkin's lymphoma

39. Expression of Cytokeratins 7 and 20 in Serrated Adenoma and Related Diseases

40. ARGON PLASMA COAGULATION: IN VIVO TISSUE DAMAGE TO THE ESOPHAGUS AND STOMACH AND CLINICAL EFFICACY FOR EARLY ESOPHAGEAL AND GASTRIC CANCER

41. Correlation between cyclooxygenase-2, proliferative activity, and mucin phenotype in human advanced gastric cancer

42. A perforin/granzyme-positive MDS-derived T cell line, K2-MDS, induces apoptosis in CD34+ cells through the fractalkine?CX3CR1 system

43. CASE REPORT: Esophageal Intramural Pseudodiverticulosis: A Case of a Young Woman

44. Localised giant haematoma and subsequent widespread purpura as a sign of acquired haemophilia A

45. Cellulitis with Leukocytopenia as an Initial Sign of Acute Promyelocytic Leukemia

46. Allergic Contact Dermatitis from Diethyl Sebacate in a Topical Antimycotic Medicament

47. Follicular Lymphoma in Osaka, Japan: Histological Features and Chronological Change

48. Effects of etodolac, a selective cyclooxygenase-2 inhibitor, on the expression of E-cadherin-catenin complexes in gastrointestinal cell lines

49. Baseline PET-Derived Metabolic Tumor Volume Metrics Predict Progression-Free and Overall Survival in DLBCL after First-Line Treatment: Results from the Phase 3 GOYA Study

50. Superimposed linear graft-versus-host disease and secondary cutaneous involvement of anaplastic large cell lymphoma